Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
Go back to Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026| (NASDAQ: TRVI) | Delayed: 16.82 -0.44 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.26 | 52 Week High | $ | |||
| Open | $16.94 | 52 Week Low | $ | |||
| Day High | $17.18 | P/E | N/A | |||
| Day Low | $16.59 | EPS | $ | |||
| Volume | 1,485,095 | |||||

